Microtubule-associated protein tau (encoded by MAPT gene) is centrally involved in the pathogenesis of Alzheimer’s disease (AD) and a group of neurodegenerative disorders coined as “tauopathies”, which display a hallmark of excessive tau aggregation in the brain [1–3]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.